drugset / Trial / NCT00177580

Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With Pravastatin

NCT00177580

RandomizedParallel-groupDouble-blindTreatment

Summary

This study supplements patients' current medications with Pravastatin, a cholesterol-lowering medication, to try to improve residual symptoms of schizophrenia, and also to improve cognitive functioning.

Timeline

Start
2003-07
Primary completion
2007-01
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Pravastatin Small molecule